Evidence map›Paper›PMID 40167339›Full record

ArticleJournal of cosmetic dermatology2025

The Kesty Redness Scale: A Pilot Validation Study for a Novel Tool for Evaluating Facial Redness in Cosmetic and Clinical Dermatology.

Chelsea E Kesty, Katarina R Kesty

Abstract readValidation Study
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chelsea E KestySt. Petersburg Skin and Laser, St. Petersburg, Florida, USA.
Katarina R KestySt. Petersburg Skin and Laser, St. Petersburg, Florida, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFacial redness is a common concern in dermatology, affecting patients with conditions such as rosacea, post-inflammatory erythema, and other vascular irregularities. Despite its prevalence, existing tools for quantifying facial redness are limited in their clinical utility and ease of use.

aimsTo develop a high-performing redness scale.

methodsThis study introduces the Kesty Redness Scale (KRS), outlines its development and validation process, and discusses its potential clinical applications.

resultsThe investigators rated the scale as useful and easy to use, and the majority stated they would use it in clinical practice to document patient characteristics. The results of the evaluation utilizing Gwet's AC2, Kendall's W, Spearman's ρ, Weighted Cohen's kappa, and Bland-Altman analysis -showcasing strong ordinal agreement, robust rank concordance, and negligible bias-demonstrate that this new rating system is both reliable and valid for measuring skin hyperpigmentation on a 0-3 scale.

conclusionsThe KRS is a reliable, easy-to-use tool that enhances the assessment of facial redness in dermatology. Its validation through expert evaluation and statistical analysis underscores its potential to improve clinical practice and research.

Indexed as

ErythemaFacial DermatosesHyperpigmentationSeverity of Illness IndexAdultDermatologyFaceFemaleHumansMaleMiddle AgedPilot ProjectsReproducibility of ResultsRosaceafacial rednesslaser resurfacingrosacearuby laserskin resurfacingvascular

Identifiers

PMID40167339
PMCPMC11960421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.